Mitchell S. Kapoor
Stock Analyst at HC Wainwright & Co.
(4.48)
# 308
Out of 5,030 analysts
36
Total ratings
61.76%
Success rate
20.33%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Mitchell S. Kapoor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HALO Halozyme Therapeutics | Reiterates: Buy | $90 | $66.88 | +34.57% | 3 | Oct 15, 2025 | |
| NGNE Neurogene | Reiterates: Buy | $45 | $33.99 | +32.39% | 1 | Oct 9, 2025 | |
| IONS Ionis Pharmaceuticals | Reiterates: Buy | $95 | $73.07 | +30.01% | 4 | Oct 8, 2025 | |
| LXEO Lexeo Therapeutics | Maintains: Buy | $9 → $15 | $8.77 | +71.04% | 2 | Oct 7, 2025 | |
| CRSP CRISPR Therapeutics AG | Reiterates: Buy | $80 | $68.43 | +16.91% | 1 | Sep 23, 2025 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $25 → $30 | $24.91 | +20.43% | 2 | Sep 19, 2025 | |
| AVTX Avalo Therapeutics | Maintains: Buy | $15 → $25 | $14.00 | +78.57% | 1 | Sep 17, 2025 | |
| SMMT Summit Therapeutics | Reiterates: Buy | $50 | $21.97 | +127.58% | 5 | Sep 16, 2025 | |
| TIL Instil Bio | Reiterates: Buy | $125 | $20.18 | +519.58% | 3 | Sep 11, 2025 | |
| BMRN BioMarin Pharmaceutical | Initiates: Neutral | $60 | $52.95 | +13.31% | 1 | Sep 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $5 | $3.96 | +26.26% | 2 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $10 | $7.01 | +42.65% | 1 | Aug 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $12.35 | +102.43% | 2 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Sell | $5 | $23.34 | -78.58% | 1 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $30 | $14.84 | +102.16% | 1 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $7 | $3.33 | +110.21% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 → $2 | $3.43 | -41.69% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $45 | $26.56 | +69.43% | 1 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $14 | $4.61 | +203.69% | 1 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $100 → $90 | $48.60 | +85.19% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.41 | +183.69% | 1 | Aug 11, 2025 |
Halozyme Therapeutics
Oct 15, 2025
Reiterates: Buy
Price Target: $90
Current: $66.88
Upside: +34.57%
Neurogene
Oct 9, 2025
Reiterates: Buy
Price Target: $45
Current: $33.99
Upside: +32.39%
Ionis Pharmaceuticals
Oct 8, 2025
Reiterates: Buy
Price Target: $95
Current: $73.07
Upside: +30.01%
Lexeo Therapeutics
Oct 7, 2025
Maintains: Buy
Price Target: $9 → $15
Current: $8.77
Upside: +71.04%
CRISPR Therapeutics AG
Sep 23, 2025
Reiterates: Buy
Price Target: $80
Current: $68.43
Upside: +16.91%
Intellia Therapeutics
Sep 19, 2025
Maintains: Buy
Price Target: $25 → $30
Current: $24.91
Upside: +20.43%
Avalo Therapeutics
Sep 17, 2025
Maintains: Buy
Price Target: $15 → $25
Current: $14.00
Upside: +78.57%
Summit Therapeutics
Sep 16, 2025
Reiterates: Buy
Price Target: $50
Current: $21.97
Upside: +127.58%
Instil Bio
Sep 11, 2025
Reiterates: Buy
Price Target: $125
Current: $20.18
Upside: +519.58%
BioMarin Pharmaceutical
Sep 8, 2025
Initiates: Neutral
Price Target: $60
Current: $52.95
Upside: +13.31%
Sep 5, 2025
Reiterates: Buy
Price Target: $5
Current: $3.96
Upside: +26.26%
Aug 29, 2025
Maintains: Buy
Price Target: $5 → $10
Current: $7.01
Upside: +42.65%
Aug 27, 2025
Reiterates: Buy
Price Target: $25
Current: $12.35
Upside: +102.43%
Aug 25, 2025
Reiterates: Sell
Price Target: $5
Current: $23.34
Upside: -78.58%
Aug 22, 2025
Reiterates: Buy
Price Target: $30
Current: $14.84
Upside: +102.16%
Aug 19, 2025
Reiterates: Buy
Price Target: $7
Current: $3.33
Upside: +110.21%
Aug 19, 2025
Maintains: Neutral
Price Target: $3 → $2
Current: $3.43
Upside: -41.69%
Aug 18, 2025
Reiterates: Buy
Price Target: $45
Current: $26.56
Upside: +69.43%
Aug 14, 2025
Reiterates: Buy
Price Target: $14
Current: $4.61
Upside: +203.69%
Aug 13, 2025
Maintains: Buy
Price Target: $100 → $90
Current: $48.60
Upside: +85.19%
Aug 11, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $1.41
Upside: +183.69%